Tools and resources

In the seventh co-partnered digital infosession from Myeloma UK and UKMS, chaired by Dr Jennifer Travers, clinicians discuss practical approaches to transplant and non-transplant decision making in myeloma, with a focus on shared decision making and real-world case discussion.

In the sixth co-partnered digital infosession from Myeloma UK and UKMS, held on 15 October 2025 and chaired by Dr Jennifer Travers, leading clinicians explored the ocular toxicities associated with belantamab mafodotin (Blenrep®). The session focused on recognising, monitoring and managing eye-related side effects to support safer and more effective treatment delivery.

In the fifth co-partnered digital infosession from Myeloma UK and UKMS, held on 26 March 2025 and chaired by Professor Guy Pratt, leading clinicians explored the pressing issue of frailty in myeloma patients. The session focused on effective strategies for assessing frailty risk and integrating these practices into everyday clinical care.

The fourth co-partnered digital infosession from Myeloma UK and UKMS, held on 16 October 2024 and hosted by Professor Gordon Cook, covers cutting-edge strategies for managing renal complications in myeloma, including myeloma cast nephropathy, paraprotein-related kidney disease, and comprehensive treatment and supportive care approaches.

Joining forces once again, Myeloma UK and the UK Myeloma Society (UKMS) proudly present their third co-partnered digital infosession. Chaired by Professor Guy Pratt, this webinar, held on 16 April 2024, brought together top experts for an engaging discussion on effective strategies for managing bone disease in myeloma patients.

Myeloma UK and the UK Myeloma Society (UKMS) are excited to present their second co-partnered digital infosession, chaired by Prof. Guy Pratt. This webinar, recorded on 18 October 2023, features leading experts discussing best practices for managing multidisciplinary clinics, offering valuable guidance for healthcare professionals involved in MGUS and myeloma care.

Myeloma UK and the UK Myeloma Society (UKMS) proudly present their first co-partnered digital infosession. This recording of the live event, held on 19 April 2023, features expert speakers from medicine, nursing, and pharmacy, sharing insights on the innovation journey of these treatments such as bispecific antibodies and offering practical guidance on their implementation and management in clinical practice.

Watch these webinars delivered in partnership with UK NEQAS that focus on the investigation, diagnosis, and management of plasma cell disorders, including MGUS, AL amyloidosis, and myeloma.

Laboratory staff are crucial to the early and accurate diagnosis of myeloma. To support their training, Myeloma UK has partnered with UK NEQAS to deliver five educational webinars, focusing on testing, reporting abnormal results, and reducing diagnostic delays.